C4 Therapeutics Inc
NASDAQ:CCCC
C4 Therapeutics Inc
Cash Taxes Paid
C4 Therapeutics Inc
Cash Taxes Paid Peer Comparison
Competitive Cash Taxes Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C4 Therapeutics Inc
NASDAQ:CCCC
|
Cash Taxes Paid
$1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Taxes Paid
$1.6B
|
CAGR 3-Years
101%
|
CAGR 5-Years
164%
|
CAGR 10-Years
88%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is C4 Therapeutics Inc's Cash Taxes Paid?
Cash Taxes Paid
1m
USD
Based on the financial report for Dec 31, 2023, C4 Therapeutics Inc's Cash Taxes Paid amounts to 1m USD.
What is C4 Therapeutics Inc's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 3Y
93%
The average annual Cash Taxes Paid growth rates for C4 Therapeutics Inc have been 93% over the past three years .